CTI BioPharma Corp. (CTIC) — Analyst outlook / Analyst consensus target is. Based on 19 analyst ratings, the consensus is bullish — 13 Buy, 6 Hold.
The consensus price target is $10.40 (low: $9.00, high: $13.00), representing an upside of 14.3% from the current price $9.10.
CTIC Stock — 12-Month Price Forecast
$10.40
▲ +14.35% Upside
Average Price Target
Based on 19 Wall Street analysts offering 12-month price targets for CTI BioPharma Corp., the average price target is $10.40, with a high forecast of $13.00, and a low forecast of $9.00.
The average price target represents a +14.35% change from the last price of $9.10.
Highest Price Target
$13.00
Average Price Target
$10.40
Lowest Price Target
$9.00
CTIC Analyst Ratings
Buy
Based on 19 analysts giving stock ratings to CTI BioPharma Corp. in the past 3 months
